Logo-hpp
2023: Two-year Impact Factor: 2.4
Scopus Journal Metrics
CiteScore (2023):7.1
  		Platinum
Open Access
Health Promot Perspect. 2020;10(2): 148-151. doi: 10.34172/hpp.2020.24
PMID: 32296628        PMCID: PMC7146039

Original Article

Clostridium difficile in patients with nosocomial diarrhea, Northwest of Iran

Yalda Hematyar 1 ORCID, Tahereh Pirzadeh 2 ORCID, Seyyed Reza Moaddab 3 ORCID, Mohammad Ahangarzadeh Rezaee 2 ORCID, Mohammad Yousef Memar 1 ORCID, Hossein Samadi Kafil 4 * ORCID

Cited by CrossRef: 2

1- Heydari H, Iranikhah A, Ghasemi A, Mohammadbeigi A, Sadat-Mirei S, Shams S, Kermani S. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea. BMC Infect Dis. 2024;24(1) [Crossref]
2- Brajerova M, Zikova J, Krutova M. Clostridioides difficile epidemiology in the Middle and the Far East. Anaerobe. 2022;74:102542 [Crossref]
3- Meng X, Huang X, Peng Z, Wang Y, Liu S, Zeng C, Duan J, Wen X, Fu C, Wu A, Li C. Antibiotic Resistances and Molecular Characteristics of Clostridioides difficile in ICUs in a Teaching Hospital From Central South China. Front Med. 2021;8 [Crossref]

Indexing and Abstracting

2-year Impact Factor: 2.4

SCOPUS CiteScore: 7.1

  Scimago Journal & Country Rank 

 

 


     Linked in Profile

   Academia Profile

Officially associated with The Iranian Health Education & Promotion Association  
Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission